However, semaglutide has proven cardiovascular benefits (SELECT trial) which are important for many diabetes patients
The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain
These include eating smaller, more frequent meals rather than large portions, avoiding eating within three hours of bedtime, elevating the head of the bed, and limiting trigger foods such as caffeine, alcohol, chocolate, and acidic foods
The clinical trial evidence is now so strong (STEP, SURMOUNT, SELECT trials) that more payers are adding GLP-1 coverage
Its approved for type 2 diabetes (Ozempic) and chronic weight management (Wegovy)
doi: 10.1021/acsnano.8b05860 202 LiJCaoFYinHLHuangZJLinZTMaoNet al